Crossmark

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Crossref DOI link: https://doi.org/10.1186/s13075-017-1256-6

Published Online: 2017-03-20

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Golder, Vera https://orcid.org/0000-0001-5691-4344
Kandane-Rathnayake, Rangi

Hoi, Alberta Yik-Bun

Huq, Molla

Louthrenoo, Worawit

An, Yuan

Li, Zhan Guo

Luo, Shue Fen

Sockalingam, Sargunan

Lau, Chak Sing

Mok, Mo Yin

Lateef, Aisha

Franklyn, Kate

Morton, Susan

Navarra, Sandra Teresa V.

Zamora, Leonid

Wu, Yeong-Jian

Hamijoyo, Laniyati

Chan, Madelynn

O’Neill, Sean

Goldblatt, Fiona

Nikpour, Mandana

Morand, Eric Francis
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1093545, APP1071735)

GlaxoSmithKline (The Asia-Pacific Lupus Collaboration receives project support grants from GlaxoSmithKline, UCB, and Janssen)

UCB (The Asia-Pacific Lupus Collaboration receives project support grants from GlaxoSmithKline, UCB, and Janssen)

Janssen Pharmaceuticals (The Asia-Pacific Lupus Collaboration receives project support grants from GlaxoSmithKline, UCB, and Janssen)